Abstract
A phosphatase which was particularly active at an acid pH was shown to be present in red blood cells in 1924 (1). Acid phosphatases are also present in leucocytes, platelets, osteoclasts, reticuloendothelial cells, and in liver, kidney, spleen and other organs. Their clinical importance derives from the fact that the concentration of the enzyme is far greater in the prostate than in any other human tissue (2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
M. Martland, F.S. Hansman and R. Robison, The phosphoric esterase of blood, Biochem. J. 18:115 (1924).
L.T. Yam, Clinical significance of the human acid phosphatase: a review, Am. J. Med. 56:604 (1974).
E.B. Gutman, E.E. Sproul and A.B. Gutman, Significance of increased phosphatase activity of bone at the site of osteoblastic metastases secondary to carcinoma of the prostate gland, Am. J. Cancer 28:485 (1936).
A.E. Reif, R.M. Schlesinger, C.A. Fish and C.M. Robinson, Acid phosphatase iso-enzymes in cancer of the prostate, Cancer 31:689 (1973).
A.B. Gutman and E.B. Gutman, An “acid” phosphatase occurring in the serum of patients with metastasising adenocarcinoma of the prostate gland, J. Clin. Invest. 17:473 (1938).
M.A. Abul-Fadl and E.J. King, Properties of the acid phosphatase of erythrocytes and of the human prostate gland, Biochem. J. 45:51 (1949).
T. M. Sodeman and J.G. Batsakis, Acid phosphatase, in: “Urologic Pathology: The Prostate,” M. Tannenbaum, ed, Lea and Febiger, Philadelphia (1979) p 129.
D.T. Chua, R.J. Veenema, F. Muggia and A. Graff, Acid phosphatase levels in bone marrow: value in detecting early bone metastases from carcinoma of the prostate, J. Urol. 103:462 (1970).
E.O. Gursel, M. Rezvan, F.A. Sy and R.J. Veenema, Comparative evaluation of bone marrow acid phosphatase v. bone scanning in staging of prostatic cancer, J. Urol. 111:53 (1974).
J.E. Pontes, S.W. Alcorn, A.J. Thomas and J.M. Piercy, Bone marrow acid phosphatase in staging prostatic carcinoma, J. Urol. 114:422 (1975).
A.W. Bruce, F. O’Cleireachan, A. Morales and S.A. Owad, Carcinoma of the prostate: A critical look at staging, J. Urol. 117:319 (1977).
R.J. Veenema, E.O. Gursel, N. Romas, M. Wechsler and J.K. Lattimer, Bone marrow acid phosphatase: Prognostic value in patients undergoing radical prostatectomy, J. Urol. 117:81 (1977).
R. Kahn, B. Turner, M. Edson and M. Dolan, Bone marrow acid phosphatase: Another look, J. Urol. 117:79 (1977).
J.E. Pontes, B.K. Choe, N.R. Rose and J.M. Pierce, Bone marrow staging of prostatic cancer: How reliable is it? J. Urol. 119:772 (1978).
A. W. Bruce, D.E. Mahan, A. Morales, A.F. Clark and W.D. Belville, An objective look at acid phosphatase determinations, Brit. J. Urol. 51:213 (1979).
S.D. Fosså, J. Sokolowsi and L. Theodorsen, The significance of bone marrow acid phosphatase in patients with prostatic carcinoma, Br. J. Urol. 50:185 (1978).
W.M. Boehme, R.R. Augsburger, S.F. Wallner and R.E. Donohue, Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer, Cancer 41:1433 (1978).
A.N. Romas, R.J. Veenema, K.C. Shu, P. Tomashefszy, J.K. Lattimer and M. Tannenbaum, Bone marrow acid phosphatase in prostatic cancer. An assessment by immuno assay and biochemical methods, J. Urol. 123:392 (1980).
S.D. Fosså, A. Skinningsrud, O. Kaalhus and A. Engeseth, Is determination of prostatic acid phosphatase in bone marrow by radioimmunoassay (BM-PAP) useful in patients with prostatic cancer, in: “Cancer of the Prostate and Kidney,” P.H. Smith and M. Pavone-Macaluso, eds., Plenum Press, London and New York (1982).
S. Shulman, L. Mamrod, M.J. Gonda and W.A. Soanes, The detection of prostatic acid phosphatase by antibody reactions in gel diffusion, J. Immunol. 93:474 (1964).
A.G Foti, H. Herschman and J.F. Cooper, Iso-enzymes of acid phosphatase in normal and cancerous human prostatic tissue, Cancer Res. 37:4120 (1977).
A.G. Foti, J.F. Cooper, H. Herschman and R.R. Malvaex, Detection of prostatic cancer by solid phase R.I.A. of serum prostatic acid phosphatase, N. Engl. J. Med. 297:1357 (1977)
T.M. Chu, M.C. Want, W.W. Scott, R.P. Gibbons, D.E. Johnson, J.D. Schmidt, S.A. Loening, G.R. Prout and G.P. Murphy, Immunochemical detection of serum prostatic acid phosphatase, Invest. Urol. 15:319 (1978).
B.K. Choe, E.J. Pontes, M.K. Morrison and N.R. Rose, Human prostatic acid phosphatases, 2: a double antibody radioimmuno assay, Arch. Androl. 1:227 (1978).
D.E. Mahan and B.P. Doctor, A radio-immune assay for human prostatic acid phosphatase levels in prostatic disease, Clin. Biochem. 12:10 (1979).
A.W. Bruce, D. Mahan and W.D. Melville, The role of radioimmuno assay for prostatic acid phosphatase in prostatic carcinoma, Urol. Clin. North Am. 12:226 (1979).
G.P. Murphy, T.M. Chu and J.P. Karr, Prostatic acid phosphatase: The developing experience, Clin. Biochem. 12:226 (1979).
J.C. Griffiths, Prostatic specific acid phosphatase, Re-evaluation of radio-immuno assay in diagnosing prostatic disease, Clin. Chem. 26:433 (1980).
K.Q. Woodward, Factors leading to elevation in serum and glycerophosphate, Cancer 5:236 (1952).
G.P. Murphy, J. Karr and T.M. Chu, Prostatic acid phosphatase: Where are we? Cancer 28:258 (1978).
Anonymous, New tests for prostatic cancer: Advisers routine, Med. World News 19:13 (1978).
R. Gittes, Acid phosphatase reappraised, New Engl. J. Med. 297:1398 (1977).
R.A. Watson and D.B. Tang, The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer, New Engl. J. Med. 303:497 (1980).
G.R. Lindholm, M.S. Stirton, R.J. Liedtke and J.D. Batjer, Prostatic acid phosphatase by radio-immuno assay, J.A.M.A. 244:2071 (1980).
L.A. Klein, Prostatic carcinoma, New Engl. J. Med. 300:824 (1979).
D.E. Johnson, W.W. Scott and R.P. Gibbons, Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma, Urology 8:123 (1976).
W.R. Berry, J. Laslo, E. Cox, A. Walker and D. Paulson, Prognostic factors in metastatic v. hormonally unresponsive carcinoma of the prostate, Cancer 44:763 (1979).
R.M. Nesbit and W.C. Baum, Serum phosphatase determination in diagnosis of prostatic cancer: A review of 1150 cases, J.A.M.A. 145:1321 (1951).
V.A.C.U.R.G., Factors in the prognosis of carcinoma of the prostate: A cooperative study, J. Urol. 100:59 (1968).
M. de Pauw, S. Suciu, R. Sylvester, P.H. Smith, M. Pavone-Macaluso and the E0RTC Urological Group, Preliminary results of two EORTC randomized trials in previously untreated patients with advanced T3 – T4 prostatic cancer, in: “Cancer of the Prostate and Kidney,” P.H. Smith and M. Pavone-Macaluso, eds., Plenum Press, London and New York (1982).
C. Huggins and C.V. Hodges, Studies on prostatic cancer: 1. The effect of castration, of oestrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate, Cancer Res. 1:293 (1941).
C.R. Franks, Melphalan in metastatic cancer of the prostate, Cancer Treat. Reviews 6 (Suppl.):121 (1979).
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Richards, B., Sylvester, R., de Pauw, M., the EORTC Urological Group. (1983). The Clinical Value of the Serum Acid Phosphatase in Carcinoma of the Prostate. In: Pavone-Macaluso, M., Smith, P.H. (eds) Cancer of the Prostate and Kidney. NATO Advanced Science Institutes Series, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4349-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4349-3_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4351-6
Online ISBN: 978-1-4684-4349-3
eBook Packages: Springer Book Archive